Tag: Amgen

NEW YORK – Amgen Inc. will pull its higher-priced version of its cholesterol drug Repatha from the market, an effort to boost sales of...

In her role as RI Bio’s executive director, Carol Malysz oversees the group’s coordination with health care organizations, life sciences companies, academic centers and...

BOSTON – Amgen Inc. will pay $13.4 billion for a blockbuster psoriasis drug from Celgene Corp., which is shedding the asset in order to...

NEW YORK – Shares of Amgen Inc. rose as much as 2.3% in pre-market trading after early results from an experimental therapy showed promise...

40 Under Forty 2019 winner: JENNIFER LYTLE | 36 QUALITY ASSURANCE MANAGER, AMGEN RHODE ISLAND What is the best advice you have ever received? Success and failures...

RI BIO, a Providence-based biotechnology trade association, is on a mission to put Rhode Island on the biotech industry’s map. Despite the state having...

Best Places to Work 2019 | ENTERPRISE (500-plus employees): 1. Amgen Rhode Island WITH CAREFUL PLANNING, Amgen Rhode Island is utilizing innovation to get its...

WEST GREENWICH – With the foundation ready, next month Amgen Inc. will begin modular construction of its $165 million next-generation biomanufacturing plant on its...

Amgen Rhode Island Exporting Excellence, 2019 PBN Manufacturing Awards While Amgen Inc.’s Rhode Island operation usually ships most of its biologic products to the drug manufacturer’s...

PROVIDENCE – A crowd of more than 320 manufacturing industry leaders attended Providence Business News’ sixth Manufacturing Awards program Wednesday at WaterFire Providence’s Valley...